Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute my
| Image |  |
|---|---|
| Description | scientific article published on 13 October 2020 |
| Author/s |
author: A Michael Lincoff John H. Alexander John J. P. Kastelein Philip Aylward Michał Tendera Paul Ridker Christoph Bode |
| Publication date | October 13, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |